RXST
RxSight, Inc.
Price Chart
Latest Quote
$4.73
+0.14 (+3.05%)
Current Price
| Previous Close | $4.59 |
| Open | $4.65 |
| Day High | $4.73 |
| Day Low | $4.59 |
| Volume | 978,771 |
Stock Information
| Shares Outstanding | 41.40M |
| Total Debt | $10.83M |
| Cash Equivalents | $217.88M |
| Revenue | $127.48M |
| Net Income | $-46.64M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $195.81M |
| EPS (TTM) | $-1.13 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-11.25M |
| Sales | $127.48M |
| Income | $-46.64M |
| Book/sh | $6.68 |
| Cash/sh | $5.26 |
| Employees | 461 |
Financial Ratios
| Quick Ratio | 8.78 |
| Current Ratio | 10.20 |
| Debt/Eq | 4.05 |
Returns & Margins
| ROA | -11.21% |
| ROE | -17.06% |
| Gross Margin | 77.02% |
| Operating Margin | -57.71% |
| Profit Margin | -36.59% |
Ownership
| Insider Ownership | 5.66% |
| Institutional Ownership | 93.05% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -8.45 |
| P/S | 1.54 |
| P/B | 0.71 |
Analyst Data
| Recommendation | none |
| Target Price | $8.79 |
Technical Indicators
| SMA20 | $5.14 |
| SMA50 | $6.09 |
| SMA200 | $8.36 |
| RSI | 35.44 |
| ATR | 0.2896 |
| Shares Float | 39.18M |
| Short Float | 10.64% |
| Short Ratio | 5.65 |
| Volatility | 1.13 |
| Rel Volume | 1.02 |
Performance History
| Week | -1.46% |
| Month | -20.50% |
| Quarter | -29.82% |
| 6 Months | -62.93% |
| YTD | -54.43% |
| Year | -64.96% |
| 3 Years | -81.94% |
| 10 Years | -70.44% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $4.73 | 978,800 |
| 2026-06-17 | $4.59 | 861,000 |
| 2026-06-16 | $4.68 | 788,000 |
| 2026-06-15 | $4.79 | 1,005,000 |
| 2026-06-12 | $4.71 | 1,008,900 |
| 2026-06-11 | $4.80 | 1,762,100 |
| 2026-06-10 | $4.60 | 844,500 |
| 2026-06-09 | $4.91 | 1,071,800 |
| 2026-06-08 | $4.95 | 646,500 |
| 2026-06-05 | $5.00 | 818,000 |
| 2026-06-04 | $5.10 | 1,171,500 |
| 2026-06-03 | $4.79 | 1,235,800 |
| 2026-06-02 | $4.94 | 1,077,900 |
| 2026-06-01 | $5.24 | 1,406,200 |
| 2026-05-29 | $5.33 | 928,400 |
| 2026-05-28 | $5.59 | 1,337,000 |
| 2026-05-27 | $5.62 | 666,400 |
| 2026-05-26 | $5.99 | 621,800 |
| 2026-05-22 | $6.09 | 399,300 |
| 2026-05-21 | $6.35 | 653,600 |
| 2026-05-20 | $6.16 | 521,200 |
| 2026-05-19 | $5.95 | 475,400 |
About RxSight, Inc.
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. RxSight, Inc. was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. The company was incorporated in 1997 and is headquartered in Aliso Viejo, California.
đ° Latest News
National Vision and Smart Glasses: Early Investing Signals
Zacks âĸ 2026-06-03T14:50:00Z
RxSight (RXST) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-12T16:04:02Z
RxSight, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-07T12:30:00Z
RxSight Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T05:12:06Z
RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-06T22:30:06Z
How The RxSight (RXST) Narrative Is Shifting After 2026 Guidance And Target Resets
Simply Wall St. âĸ 2026-05-04T04:31:08Z
How The RxSight (RXST) Story Is Shifting With New Guidance And Street Price Targets
Simply Wall St. âĸ 2026-04-19T08:04:12Z
How The Story Is Shifting For RxSight (RXST) On Guidance Leadership And Valuation
Simply Wall St. âĸ 2026-04-05T06:09:56Z
How The RxSight (RXST) Investment Story Is Shifting With New Guidance And CFO Transition
Simply Wall St. âĸ 2026-03-21T14:05:08Z
How The RxSight (RXST) Investment Story Is Shifting With New Guidance And CFO Change
Simply Wall St. âĸ 2026-03-07T03:13:22Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $31,470,000 | $40,984,000 | $35,312,000 | $27,677,000 |
| Cost Of Revenue | $31,470,000 | $40,984,000 | $35,312,000 | $27,677,000 |
| Total Revenue | $134,479,000 | $139,927,000 | $89,077,000 | $49,005,000 |
| Operating Revenue | $134,479,000 | $139,927,000 | $89,077,000 | $49,005,000 |
| Expenses | ||||
| Interest Expense | $19,000 | $21,000 | $3,308,000 | $4,946,000 |
| Total Expenses | $182,670,000 | $176,785,000 | $139,162,000 | $112,323,000 |
| Net Non Operating Interest Income Expense | $9,313,000 | $9,453,000 | $3,266,000 | $-3,429,000 |
| Interest Expense Non Operating | $19,000 | $21,000 | $3,308,000 | $4,946,000 |
| Operating Expense | $151,200,000 | $135,801,000 | $103,850,000 | $84,646,000 |
| Other Income Expense | - | - | $-1,769,000 | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-38,944,000 | $-27,455,000 | $-48,608,000 | $-66,756,000 |
| Net Interest Income | $9,313,000 | $9,453,000 | $3,266,000 | $-3,429,000 |
| Interest Income | $9,332,000 | $9,474,000 | $6,574,000 | $1,517,000 |
| Normalized Income | $-38,944,000 | $-27,455,000 | $-46,839,000 | $-66,756,000 |
| Net Income From Continuing And Discontinued Operation | $-38,944,000 | $-27,455,000 | $-48,608,000 | $-66,756,000 |
| Total Operating Income As Reported | $-48,191,000 | $-36,858,000 | $-50,085,000 | $-63,318,000 |
| Net Income Common Stockholders | $-38,944,000 | $-27,455,000 | $-48,608,000 | $-66,756,000 |
| Net Income | $-38,944,000 | $-27,455,000 | $-48,608,000 | $-66,756,000 |
| Net Income Including Noncontrolling Interests | $-38,944,000 | $-27,455,000 | $-48,608,000 | $-66,756,000 |
| Net Income Continuous Operations | $-38,944,000 | $-27,455,000 | $-48,608,000 | $-66,756,000 |
| Pretax Income | $-38,878,000 | $-27,405,000 | $-48,588,000 | $-66,747,000 |
| Special Income Charges | $0 | $0 | $-1,769,000 | $0 |
| Interest Income Non Operating | $9,332,000 | $9,474,000 | $6,574,000 | $1,517,000 |
| Operating Income | $-48,191,000 | $-36,858,000 | $-50,085,000 | $-63,318,000 |
| Gross Profit | $103,009,000 | $98,943,000 | $53,765,000 | $21,328,000 |
| Per Share | ||||
| Diluted EPS | $-0.95 | $-0.71 | $-1.41 | $-2.41 |
| Basic EPS | $-0.95 | $-0.71 | $-1.41 | $-2.41 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-35,593,000 | $-23,809,000 | $-39,433,000 | $-57,779,000 |
| Total Unusual Items | $0 | $0 | $-1,769,000 | $0 |
| Total Unusual Items Excluding Goodwill | $0 | $0 | $-1,769,000 | $0 |
| Reconciled Depreciation | $3,266,000 | $3,575,000 | $4,078,000 | $4,022,000 |
| EBITDA (Bullshit earnings) | $-35,593,000 | $-23,809,000 | $-41,202,000 | $-57,779,000 |
| EBIT | $-38,859,000 | $-27,384,000 | $-45,280,000 | $-61,801,000 |
| Diluted Average Shares | $40,850,739 | $38,867,726 | $34,455,111 | $27,661,982 |
| Basic Average Shares | $40,850,739 | $38,867,726 | $34,455,111 | $27,661,982 |
| Diluted NI Availto Com Stockholders | $-38,944,000 | $-27,455,000 | $-48,608,000 | $-66,756,000 |
| Tax Provision | $66,000 | $50,000 | $20,000 | $9,000 |
| Research And Development | $38,549,000 | $34,367,000 | $29,051,000 | $25,981,000 |
| Selling General And Administration | $112,651,000 | $101,434,000 | $74,799,000 | $58,665,000 |
| Other Special Charges | - | - | $1,769,000 | - |
| Otherunder Preferred Stock Dividend | - | - | - | - |
| Gain On Sale Of Ppe | - | - | - | - |
| Gain On Sale Of Security | - | - | - | - |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $275,683,000 | $281,238,000 | $160,362,000 | $89,902,000 |
| Total Assets | $311,814,000 | $318,563,000 | $182,550,000 | $150,164,000 |
| Total Non Current Assets | $24,355,000 | $24,740,000 | $14,143,000 | $15,609,000 |
| Other Non Current Assets | $1,340,000 | $1,110,000 | $858,000 | $1,528,000 |
| Current Assets | $287,459,000 | $293,823,000 | $168,407,000 | $134,555,000 |
| Other Current Assets | $4,389,000 | $4,541,000 | $3,523,000 | $2,962,000 |
| Inventory | $31,559,000 | $22,009,000 | $17,421,000 | $14,835,000 |
| Receivables | $23,383,000 | $30,050,000 | $20,281,000 | $10,956,000 |
| Accounts Receivable | $23,383,000 | $30,050,000 | $20,281,000 | $10,956,000 |
| Cash Cash Equivalents And Short Term Investments | $228,128,000 | $237,223,000 | $127,182,000 | $105,802,000 |
| Cash And Cash Equivalents | $19,949,000 | $16,706,000 | $9,692,000 | $11,834,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $11,040,000 | $12,296,000 | $3,012,000 | $44,995,000 |
| Long Term Debt And Capital Lease Obligation | $9,878,000 | $11,322,000 | $1,211,000 | $43,025,000 |
| Current Debt And Capital Lease Obligation | $1,162,000 | $974,000 | $1,801,000 | $1,970,000 |
| Net Debt | - | - | - | $28,335,000 |
| Long Term Debt | - | - | - | $40,169,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $36,131,000 | $37,325,000 | $22,188,000 | $60,262,000 |
| Total Non Current Liabilities Net Minority Interest | $9,878,000 | $11,449,000 | $1,285,000 | $43,025,000 |
| Current Liabilities | $26,253,000 | $25,876,000 | $20,903,000 | $17,237,000 |
| Other Current Liabilities | $5,705,000 | $2,788,000 | $2,557,000 | $2,332,000 |
| Current Deferred Liabilities | $3,600,000 | $3,110,000 | $2,045,000 | $1,348,000 |
| Payables And Accrued Expenses | $5,296,000 | $4,544,000 | $3,863,000 | $3,050,000 |
| Payables | $5,296,000 | $4,544,000 | $3,863,000 | $2,595,000 |
| Accounts Payable | $5,296,000 | $4,544,000 | $3,863,000 | $2,595,000 |
| Other Non Current Liabilities | - | $127,000 | $74,000 | - |
| Interest Payable | - | - | $0 | $455,000 |
| Derivative Product Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $275,683,000 | $281,238,000 | $160,362,000 | $89,902,000 |
| Total Equity Gross Minority Interest | $275,683,000 | $281,238,000 | $160,362,000 | $89,902,000 |
| Stockholders Equity | $275,683,000 | $281,238,000 | $160,362,000 | $89,902,000 |
| Gains Losses Not Affecting Retained Earnings | $53,000 | $166,000 | $-5,000 | $-95,000 |
| Other Equity Adjustments | $53,000 | $166,000 | $-5,000 | $-95,000 |
| Retained Earnings | $-661,039,000 | $-622,095,000 | $-594,640,000 | $-546,032,000 |
| Other | ||||
| Ordinary Shares Number | $41,242,005 | $40,428,220 | $36,139,513 | $28,268,389 |
| Share Issued | $41,242,005 | $40,428,220 | $36,139,513 | $28,268,389 |
| Tangible Book Value | $275,683,000 | $281,238,000 | $160,362,000 | $89,902,000 |
| Invested Capital | $275,683,000 | $281,238,000 | $160,362,000 | $130,071,000 |
| Working Capital | $261,206,000 | $267,947,000 | $147,504,000 | $117,318,000 |
| Capital Lease Obligations | $11,040,000 | $12,296,000 | $3,012,000 | $4,826,000 |
| Total Capitalization | $275,683,000 | $281,238,000 | $160,362,000 | $130,071,000 |
| Additional Paid In Capital | $936,628,000 | $903,127,000 | $754,971,000 | $636,001,000 |
| Capital Stock | $41,000 | $40,000 | $36,000 | $28,000 |
| Common Stock | $41,000 | $40,000 | $36,000 | $28,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $9,878,000 | $11,322,000 | $1,211,000 | $2,856,000 |
| Current Deferred Revenue | $3,600,000 | $3,110,000 | $2,045,000 | $1,348,000 |
| Current Capital Lease Obligation | $1,162,000 | $974,000 | $1,801,000 | $1,970,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $10,490,000 | $14,460,000 | $10,637,000 | $8,537,000 |
| Net PPE | $23,015,000 | $23,630,000 | $13,285,000 | $14,081,000 |
| Accumulated Depreciation | $-26,568,000 | $-25,428,000 | $-22,698,000 | $-19,898,000 |
| Gross PPE | $49,583,000 | $49,058,000 | $35,983,000 | $33,979,000 |
| Leases | $15,166,000 | $14,246,000 | $11,553,000 | $11,206,000 |
| Construction In Progress | $1,720,000 | $1,543,000 | $2,335,000 | $1,331,000 |
| Other Properties | $11,705,000 | $13,824,000 | $4,605,000 | $6,022,000 |
| Machinery Furniture Equipment | $20,992,000 | $19,445,000 | $17,490,000 | $15,420,000 |
| Properties | $0 | $0 | $0 | $0 |
| Inventories Adjustments Allowances | $-1,972,000 | $-613,000 | $-496,000 | $-634,000 |
| Finished Goods | $21,635,000 | $12,029,000 | $8,092,000 | $6,408,000 |
| Work In Process | $3,555,000 | $3,484,000 | $4,145,000 | $2,567,000 |
| Raw Materials | $8,341,000 | $7,109,000 | $5,680,000 | $6,494,000 |
| Other Short Term Investments | $208,179,000 | $220,517,000 | $117,490,000 | $93,968,000 |
| Current Accrued Expenses | - | - | $0 | $455,000 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-19,341,000 | $-22,386,000 | $-46,407,000 | $-61,243,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-15,511,000 | $-16,946,000 | $-41,593,000 | $-58,850,000 |
| Cash Flow From Continuing Operating Activities | $-15,511,000 | $-16,946,000 | $-41,593,000 | $-58,850,000 |
| Operating Gains Losses | - | - | $1,769,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-3,830,000 | $-5,440,000 | $-4,814,000 | $-2,393,000 |
| Investing Cash Flow | $16,889,000 | $-99,311,000 | $-22,129,000 | $39,950,000 |
| Cash Flow From Continuing Investing Activities | $16,889,000 | $-99,311,000 | $-22,129,000 | $39,950,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $3,951,000 | $128,916,000 | $105,957,000 | $7,828,000 |
| Financing Cash Flow | $1,863,000 | $123,319,000 | $61,524,000 | $6,332,000 |
| Cash Flow From Continuing Financing Activities | $1,863,000 | $123,319,000 | $61,524,000 | $6,332,000 |
| Net Other Financing Charges | $-2,062,000 | $-5,536,000 | $-4,280,000 | $-1,375,000 |
| Net Common Stock Issuance | $3,951,000 | $128,916,000 | $105,957,000 | $7,828,000 |
| Common Stock Issuance | $3,951,000 | $128,916,000 | $105,957,000 | $7,828,000 |
| Other | ||||
| Repayment Of Debt | $-26,000 | $-61,000 | $-60,153,000 | $-121,000 |
| Issuance Of Debt | $0 | $0 | $20,000,000 | $0 |
| Interest Paid Supplemental Data | $0 | $0 | $3,464,000 | $4,257,000 |
| Income Tax Paid Supplemental Data | $58,000 | $24,000 | $8,000 | $3,000 |
| End Cash Position | $20,699,000 | $17,456,000 | $10,403,000 | $12,595,000 |
| Beginning Cash Position | $17,456,000 | $10,403,000 | $12,595,000 | $25,172,000 |
| Effect Of Exchange Rate Changes | $3,000 | $-9,000 | $6,000 | $-9,000 |
| Changes In Cash | $3,240,000 | $7,062,000 | $-2,198,000 | $-12,568,000 |
| Net Issuance Payments Of Debt | $-26,000 | $-61,000 | $-40,153,000 | $-121,000 |
| Net Long Term Debt Issuance | $-26,000 | $-61,000 | $-40,153,000 | $-121,000 |
| Long Term Debt Payments | $-26,000 | $-61,000 | $-60,153,000 | $-121,000 |
| Long Term Debt Issuance | $0 | $0 | $20,000,000 | $0 |
| Net Investment Purchase And Sale | $20,719,000 | $-93,871,000 | $-17,315,000 | $42,343,000 |
| Sale Of Investment | $260,000,000 | $243,000,000 | $255,000,000 | $255,000,000 |
| Purchase Of Investment | $-239,281,000 | $-336,871,000 | $-272,315,000 | $-212,657,000 |
| Net PPE Purchase And Sale | $-3,830,000 | $-5,440,000 | $-4,814,000 | $-2,393,000 |
| Purchase Of PPE | $-3,830,000 | $-5,440,000 | $-4,814,000 | $-2,393,000 |
| Change In Working Capital | $-4,892,000 | $-9,162,000 | $-8,907,000 | $-7,412,000 |
| Change In Payables And Accrued Expense | $-1,248,000 | $6,815,000 | $3,564,000 | $5,448,000 |
| Change In Accrued Expense | $-1,875,000 | $5,869,000 | $2,314,000 | $4,813,000 |
| Change In Payable | $627,000 | $946,000 | $1,250,000 | $635,000 |
| Change In Account Payable | $627,000 | $946,000 | $1,250,000 | $635,000 |
| Change In Prepaid Assets | $1,183,000 | $-1,181,000 | $-397,000 | $789,000 |
| Change In Inventory | $-11,482,000 | $-4,993,000 | $-2,749,000 | $-7,555,000 |
| Change In Receivables | $6,655,000 | $-9,803,000 | $-9,325,000 | $-6,094,000 |
| Changes In Account Receivables | $6,655,000 | $-9,803,000 | $-9,325,000 | $-6,094,000 |
| Stock Based Compensation | $31,612,000 | $24,635,000 | $15,746,000 | $11,397,000 |
| Provisionand Write Offof Assets | $1,964,000 | $438,000 | $164,000 | $752,000 |
| Amortization Of Securities | $-8,517,000 | $-8,977,000 | $-6,122,000 | $-1,405,000 |
| Depreciation Amortization Depletion | $3,266,000 | $3,575,000 | $4,078,000 | $4,022,000 |
| Depreciation And Amortization | $3,266,000 | $3,575,000 | $4,078,000 | $4,022,000 |
| Depreciation | $3,266,000 | $3,575,000 | $4,078,000 | $4,022,000 |
| Net Income From Continuing Operations | $-38,944,000 | $-27,455,000 | $-48,608,000 | $-66,756,000 |
| Other Non Cash Items | - | - | $287,000 | $552,000 |
| Proceeds From Stock Option Exercised | - | - | - | $1,778,000 |
| Sale Of PPE | - | - | - | - |
| Gain Loss On Investment Securities | - | - | - | - |
| Gain Loss On Sale Of PPE | - | - | - | - |
Fetched: 2026-06-20